-
The Board of Directors of FRISQ Holding AB have entered into an LoI for an acquisition of NOSA – a medtech company with a unique nasal protection and substance delivery technology
The board of directors of FRISQ Holding AB (FRISQ) has signed a Letter of Intent (LoI) with the major shareholders of NoseOption AB (NOSA) with organization number 556861-2294 (https://nosamed.com) to aquire 100% of the shares of NOSA. The deal will be conditional of a short due diligence phase and a FRISQ shareholder acceptance from an …
More -
FRISQ Holding AB completes the transaction to divest FRISQ AB to Cambio
FRISQ Holding AB (FRISQ) and Cambio Healthcare Systems AB (Cambio) has today completed the transaction of the earlier communicated divestment of FRISQ AB to Cambio. In line with the Share Purchase Agreement signed by both parties on the 31st of October 22, Cambio has paid in cash SEK 31 million as the first payment installment …
More -
FRISQ’s Interim Report Q3, 2022
CEO StatementAfter an extensive evaluation of the best options to secure FRISQs long-term economic stability and a broader introduction of individualized, interactive care plans that create value for both patients and healthcare staff in Sweden, the board of FRISQ Holding AB has accepted an offer to divest the operational business (in practice the subsidiary FRISQ …
More -
FRISQ Holding AB divests its operational business to Cambio for SEK 40 million
On Monday 31 October 2022 at an extra shareholder’s meeting, a decision was taken to accept the previously communicated binding, conditional offer from Cambio Healthcare Systems AB ("Cambio") to acquire FRISQ's operational business for SEK 40 million. The board intends to replace FRISQ AB with an acquisition of a new business during Q4 2022. Cambio's …
More -
Announcement from FRISQ’s extra general meeting
The extra general meeting ("EGM") of Frisq Holding AB (publ) ("FRISQ" or the "Company") was held today on 31 October 2022 and the following resolutions were passed by the meeting. Resolution on approval of the sale of all shares in the subsidiaryThe EGM resolved, in accordance with the board of directors' proposal, to approve the sale …
More -
FRISQ’S Board of Directors recommends a divestment of the operational business to Cambio for SEK 40 million and intends to acquire a new business
The Board of FRISQ Holding AB ("FRISQ") has received a binding, conditional offer from Cambio Healthcare Systems AB ("Cambio") of SEK 40 million for aquiring FRISQ's operational business. The Board will call an extraordinary general meeting on October 31 and recommends to the shareholders that the offer should be accepted. The Board intends to replace …
More